Mullerian adenosarcoma of the female genital tract
- PMID: 20179434
- DOI: 10.1097/PAP.0b013e3181cfe732
Mullerian adenosarcoma of the female genital tract
Abstract
Mullerian adenosarcoma is an uncommon, but not rare, mixed tumor containing a neoplastic but benign or mildly atypical epithelial element and a sarcomatous, usually low-grade, stromal component. The most common site is the uterine corpus but adenosarcoma also occurs in the cervix and ovary and more rarely in the vagina, fallopian tube, arising from peritoneal surfaces, or outside the female genital tract, for example in the intestine. Most uterine cases have a polypoid gross appearance, sometimes resulting in the formation of multiple polyps. Characteristic histologic features include a low power "phyllodes-like" architecture with leaf-like projections lined by a variety of benign Mullerian type epithelia, sometimes with squamous metaplasia. Intraglandular stromal protrusions are a characteristic feature. The stroma may be uniformly cellular but there is typically increased cellularity around the epithelial elements, resulting in the formation of a cambium layer. Using the World Health Organization definition, stromal mitotic activity of 2 or more per 10 high-power fields is required for a diagnosis of adenosarcoma but in practice the diagnosis is made with stromal mitotic activity less than this if the characteristic architecture and cambium layer is present. The stromal component is usually morphologically "low-grade" and of endometrial stromal or fibroblastic type (hormone receptor and CD10 positive). Sometimes it is high grade, resembling undifferentiated sarcoma. Additional features sometimes present include heterologous stromal elements or sex cord-like differentiation. Uterine adenosarcomas are, in general, low-grade neoplasms capable of local recurrence after polypectomy or hysterectomy and much less commonly distant metastasis. The 2 most important adverse prognostic factors, which sometimes coexist, are deep myometrial invasion and sarcomatous overgrowth; the latter is usually associated with morphologically "high-grade" stromal elements with loss of expression of hormone receptors and CD10. Adenosarcoma may be confused with a variety of lesions and one of the main differential diagnoses is adenofibroma in which the stromal component is, by definition, morphologically benign. However, occasional adenofibromas recur or even metastasize. As such, it has been suggested that all adenofibromas should be classified as adenosarcomas, albeit with low-malignant potential. Ovarian adenosarcomas are much more likely to exhibit malignant behavior than their uterine counterparts, probably due to the lack of an anatomic barrier to peritoneal dissemination.
Similar articles
-
Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma.Am J Surg Pathol. 2009 Feb;33(2):278-88. doi: 10.1097/PAS.0b013e318181a80d. Am J Surg Pathol. 2009. PMID: 18941402
-
Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases.Am J Surg Pathol. 2008 Jul;32(7):1013-21. doi: 10.1097/PAS.0b013e318161d1be. Am J Surg Pathol. 2008. PMID: 18469708
-
Müllerian adenosarcoma presenting as cervical polyps: a report of seven cases and review of the literature.Obstet Gynecol. 1993 May;81(5 ( Pt 1)):655-9. Obstet Gynecol. 1993. PMID: 8385764 Review.
-
Pathology of mixed Müllerian tumours.Best Pract Res Clin Obstet Gynaecol. 2011 Dec;25(6):705-18. doi: 10.1016/j.bpobgyn.2011.05.010. Epub 2011 Jul 13. Best Pract Res Clin Obstet Gynaecol. 2011. PMID: 21742560 Review.
-
Uterine adenosarcomas overgrown by sex-cord-like tumour: report of two cases.J Clin Pathol. 2009 Oct;62(10):942-4. doi: 10.1136/jcp.2008.063727. J Clin Pathol. 2009. PMID: 19783725
Cited by
-
Uterine adenosarcoma arising from a subserosal adenomyoma: A case report.Gynecol Oncol Rep. 2022 Mar 8;40:100957. doi: 10.1016/j.gore.2022.100957. eCollection 2022 Apr. Gynecol Oncol Rep. 2022. PMID: 35284611 Free PMC article.
-
BCOR Expression in Mullerian Adenosarcoma: A Potential Diagnostic Pitfall.Am J Surg Pathol. 2020 Jun;44(6):765-770. doi: 10.1097/PAS.0000000000001445. Am J Surg Pathol. 2020. PMID: 32011345 Free PMC article.
-
Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors.Mod Pathol. 2022 Nov;35(11):1684-1694. doi: 10.1038/s41379-022-01160-1. Epub 2022 Sep 22. Mod Pathol. 2022. PMID: 36138078 Free PMC article.
-
Uterine Adenosarcoma: a Review.Curr Oncol Rep. 2016 Nov;18(11):68. doi: 10.1007/s11912-016-0552-7. Curr Oncol Rep. 2016. PMID: 27718181 Review.
-
Clinicopathological analysis of 22 Müllerian adenosarcomas and the sequencing of DICER1 mutation.Diagn Pathol. 2024 Apr 3;19(1):56. doi: 10.1186/s13000-024-01477-2. Diagn Pathol. 2024. PMID: 38570882 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials